Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people she said are most vulnerable to the disease.

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the ...

The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

“With the risk of a ‘tripledemic’ of winter viruses – COVID, flu and RSV – if you are pregnant or aged 75 to 79, it is also ...

2 Does vaccination for respiratory syncytial virus (RSV) during pregnancy reduce the number of infants hospitalized with RSV infection? That was the question at the core of this literature review.

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

The Kansas Department of Health and Environment (KDHE) wants to remind Kansans to remain aware of symptoms, preventative ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research from the University of Aberdeen and the MRC-University of Glasgow Center ...